Effectiveness and safety of dupilumab in the treatment of pediatric atopic dermatitis: a real-world study from China
BackgroundAtopic dermatitis (AD), a common chronic inflammatory skin disorder in children, often shows limited response to conventional therapies with potential adverse effects.MethodsThis real-world study evaluated dupilumab—a monoclonal antibody targeting IL-4/IL-13 signaling—in 59 Chinese pediatr...
Saved in:
| Main Authors: | Yue Xu, Bowen Li, Wenge Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1644875/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A pediatric case of dupilumab-induced pustular psoriasis
by: Nan Dang, et al.
Published: (2024-12-01) -
High Prevalence of Lash Collarettes in Patients with Atopic Dermatitis Treated with Dupilumab
by: Ilaria Trave, et al.
Published: (2025-08-01) -
Injection site reactions after dupilumab or tralokinumab for atopic dermatitis
by: Fabrizio Martora, et al.
Published: (2024-12-01) -
The Effect of Dupilumab on Growth Parameters in Pediatric Atopic Dermatitis Patients
by: Vincenzo Piccolo, et al.
Published: (2025-07-01) -
Experience with dupilumab in patients with atopic dermatitis
by: E. A. Glukhova, et al.
Published: (2023-07-01)